Evidence map›Paper›PMID 42547472›Full record

ArticleAllergy, asthma & immunology research2026

Subtype-Specific Efficacy of Topical

Jiseung Kang, Yesol Yim, Haeun Lee, So Min Kang, Dong-Geol Lee, Young Mok Heo, Hyungwoo Jo, Seunghyun Kang, Hyeon Jin Kim, Dong Keon Yon and 1 more

Abstract read
In one paragraph

Article in Allergy, asthma & immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiseung KangSchool of Health and Environmental Science, College of Health Science, Korea University, Seoul, Korea.ORCID https://orcid.org/0000-0002-3734-7572
Yesol YimCenter for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0006-3618-2354
Haeun LeeResearch and Innovation Center, Cosmax BTI, Seongnam, Korea.ORCID https://orcid.org/0000-0002-9415-0557
So Min KangKorea Biomedical Research Institute, Seongnam, Korea.ORCID https://orcid.org/0000-0002-1055-4491
Dong-Geol LeeResearch and Innovation Center, Cosmax BTI, Seongnam, Korea.ORCID https://orcid.org/0009-0006-1684-7128
Young Mok HeoResearch and Innovation Center, Cosmax BTI, Seongnam, Korea.ORCID https://orcid.org/0000-0002-4060-5018
Hyungwoo JoResearch and Innovation Center, Cosmax BTI, Seongnam, Korea.ORCID https://orcid.org/0000-0001-7727-5238
Seunghyun Kang *Research and Innovation Center, Cosmax BTI, Seongnam, Korea.ORCID https://orcid.org/0000-0002-9318-8318
Hyeon Jin Kim *Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1286-4669
Dong Keon Yon *Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1628-9948
Christa J NehsMass General Brigham Department of Anesthesiology, Massachusetts General Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-6708-1656

Funding

Ministry of Health and Welfare RS-2025-02220492
6 · The paper itself

Abstract

Topical

Indexed as

Atopic dermatitisemollientpost bioticsskin microbiometherapeutic uses

Identifiers

PMID42547472
PMCPMC13441554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.